Janney Montgomery Scott LLC increased its holdings in shares of Danaher Co. (NYSE:DHR) by 6.2% during the 3rd quarter, HoldingsChannel reports. The firm owned 118,488 shares of the conglomerate’s stock after purchasing an additional 6,897 shares during the period. Janney Montgomery Scott LLC’s holdings in Danaher were worth $12,875,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in DHR. Principal Financial Group Inc. raised its position in Danaher by 2.2% in the 1st quarter. Principal Financial Group Inc. now owns 1,915,209 shares of the conglomerate’s stock valued at $187,519,000 after buying an additional 40,320 shares during the last quarter. Xact Kapitalforvaltning AB raised its position in Danaher by 4.2% in the 2nd quarter. Xact Kapitalforvaltning AB now owns 121,458 shares of the conglomerate’s stock valued at $11,985,000 after buying an additional 4,862 shares during the last quarter. Raymond James Trust N.A. raised its position in Danaher by 15.5% in the 2nd quarter. Raymond James Trust N.A. now owns 10,119 shares of the conglomerate’s stock valued at $999,000 after buying an additional 1,357 shares during the last quarter. Addenda Capital Inc. raised its position in Danaher by 91.5% in the 2nd quarter. Addenda Capital Inc. now owns 87,697 shares of the conglomerate’s stock valued at $8,633,000 after buying an additional 41,895 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. raised its position in Danaher by 20.2% in the 2nd quarter. NN Investment Partners Holdings N.V. now owns 6,677 shares of the conglomerate’s stock valued at $659,000 after buying an additional 1,123 shares during the last quarter. Institutional investors and hedge funds own 76.80% of the company’s stock.

NYSE:DHR opened at $104.39 on Friday. The company has a market cap of $72.94 billion, a price-to-earnings ratio of 25.90, a P/E/G ratio of 2.00 and a beta of 1.04. Danaher Co. has a twelve month low of $91.65 and a twelve month high of $110.13. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.03. The firm had revenue of $4.85 billion for the quarter, compared to analyst estimates of $4.80 billion. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The business’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.00 EPS. Research analysts forecast that Danaher Co. will post 4.51 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, October 26th. Shareholders of record on Friday, September 28th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.61%. The ex-dividend date of this dividend was Thursday, September 27th. Danaher’s dividend payout ratio (DPR) is 15.88%.

A number of equities research analysts recently issued reports on the company. Robert W. Baird dropped their target price on Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research report on Friday, October 19th. Zacks Investment Research lowered Danaher from a “buy” rating to a “hold” rating in a research report on Friday, October 12th. Morgan Stanley lifted their target price on Danaher from $122.00 to $126.00 and gave the company an “overweight” rating in a research report on Wednesday, October 10th. Royal Bank of Canada lifted their target price on Danaher to $107.00 and gave the company a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. Finally, Bank of America set a $113.00 target price on Danaher and gave the company a “buy” rating in a research report on Thursday, July 19th. One equities research analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Danaher presently has an average rating of “Buy” and an average price target of $112.14.

In other Danaher news, insider Thomas Patrick Joyce, Jr. sold 5,212 shares of the business’s stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $103.89, for a total transaction of $541,474.68. Following the transaction, the insider now owns 151,829 shares of the company’s stock, valued at approximately $15,773,514.81. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Daniel L. Comas sold 36,000 shares of the business’s stock in a transaction that occurred on Thursday, November 8th. The stock was sold at an average price of $103.88, for a total value of $3,739,680.00. Following the transaction, the chief financial officer now directly owns 124,218 shares in the company, valued at approximately $12,903,765.84. The disclosure for this sale can be found here. Insiders have sold a total of 150,007 shares of company stock worth $15,202,163 in the last ninety days. Insiders own 11.90% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Danaher Co. (DHR) Stake Boosted by Janney Montgomery Scott LLC” was first reported by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2018/11/10/danaher-co-dhr-stake-boosted-by-janney-montgomery-scott-llc.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Story: How accurate is the Rule of 72?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.